Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 8, Issue 2, 1995, Pages 141-151

  Cheeseman, S H ^a   Havlir, D ^a   McLaughlin, M M ^a   Greenough, T C ^a   Sullivan, J L ^a   Hall, D ^a   Hattox, S E ^a   Spector, S A ^a   Stein, D S ^a   Myers, M ^a   Richman, D D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

combination therapy; nevirapine; nonnucleoside reverse transcriptase inhibitor; pharmacokinetics; phase I II study

Indexed keywords

NEVIRAPINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG BLOOD LEVEL; DRUG COMBINATION; DRUG RESISTANCE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SEDATION; SIDE EFFECT; SOMNOLENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0028900894     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199502000-00005     Document Type: Article

References (0)